Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax‐based therapy
Work
Year: 2024
Type: article
Abstract: Background Acute myeloid leukemia (AML) is a heterogeneous disease, and its heterogeneity is associated with treatment response. Despite the demonstrated success of venetoclax (VEN)‐based therapy for... more
Source: Cancer Medicine
Institutions Shenzhen Second People's Hospital, Shenzhen Blood Center, Southern Medical University, Nanfang Hospital, Southern Medical University Shenzhen Hospital +8 more
Cites: 34
Cited by: 1
Related to: 10
FWCI: 1.515
Citation percentile (by year/subfield): 81.06
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $3,025